Plain-English translation of NCT06046118 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Age-Related Macular Degeneration research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called photobiomodulation—using special yellow and red lights directed at your eyes—to see if it can help slow down dry age-related macular degeneration (AMD) and improve your vision. Researchers want to know if this light therapy can reduce drusen (fatty deposits in the eye) and help you see better. Half of the participants will receive the real light treatment, and half will receive a sham (fake) treatment to compare results fairly.
Dry AMD is a common cause of vision loss in older adults, and there are limited treatment options available. This trial exists to find out whether this non-invasive light therapy could offer a new way to slow the disease and preserve sight.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will come in twice per week for 7 weeks total, split into two cycles. During each visit, you'll receive light therapy sessions: first, 5 minutes of continuous yellow light with your eyes closed, followed by 1 minute of pulsed yellow light with your eyes open, then the same sequence with red light. The sessions are painless and non-invasive. Researchers will test your vision and take eye images before and after treatment to see if the light therapy helps.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Italy
Turkey (Türkiye)